Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection
Abstract Characterizing the antigen‐binding and innate immune‐recruiting properties of the humoral response offers the chance to obtain deeper insights into mechanisms of protection than revealed by measuring only overall antibody titer. Here, a high‐throughput, multiplexed Fab‐Fc Array was employed...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-05-01
|
Series: | Molecular Systems Biology |
Subjects: | |
Online Access: | https://doi.org/10.15252/msb.20188747 |
id |
doaj-dc54b0b9fb6b43ac8f6641ea44113f31 |
---|---|
record_format |
Article |
spelling |
doaj-dc54b0b9fb6b43ac8f6641ea44113f312021-08-02T06:17:09ZengWileyMolecular Systems Biology1744-42922019-05-01155n/an/a10.15252/msb.20188747Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protectionSrivamshi Pittala0Kenneth Bagley1Jennifer A Schwartz2Eric P Brown3Joshua A Weiner4Ilia J Prado5Wenlei Zhang6Rong Xu7Ayuko Ota‐Setlik8Ranajit Pal9Xiaoying Shen10Charles Beck11Guido Ferrari12George K Lewis13Celia C LaBranche14David C Montefiori15Georgia D Tomaras16Galit Alter17Mario Roederer18Timothy R Fouts19Margaret E Ackerman20Chris Bailey‐Kellogg21Department of Computer Science Dartmouth Hanover NH USAProfectus BioSciences, Inc. Baltimore MD USAProfectus BioSciences, Inc. Baltimore MD USAThayer School of Engineering Dartmouth Hanover NH USAThayer School of Engineering Dartmouth Hanover NH USAProfectus BioSciences, Inc. Baltimore MD USAProfectus BioSciences, Inc. Baltimore MD USAProfectus BioSciences, Inc. Baltimore MD USAProfectus BioSciences, Inc. Baltimore MD USAAdvanced Bioscience Laboratories, Inc. Rockville MD USADuke Human Vaccine Institute Durham NC USADepartment of Surgery Duke University Medical Center Durham NC USADepartment of Surgery Duke University Medical Center Durham NC USAInstitute for Human Virology University of Maryland School of Medicine Baltimore MD USADepartment of Surgery Duke University Medical Center Durham NC USADuke University Durham NC USADuke Human Vaccine Institute Durham NC USAHarvard Medical School Boston MA USAVaccine Research Center NIAID NIH Bethesda MD USAProfectus BioSciences, Inc. Baltimore MD USAThayer School of Engineering Dartmouth Hanover NH USADepartment of Computer Science Dartmouth Hanover NH USAAbstract Characterizing the antigen‐binding and innate immune‐recruiting properties of the humoral response offers the chance to obtain deeper insights into mechanisms of protection than revealed by measuring only overall antibody titer. Here, a high‐throughput, multiplexed Fab‐Fc Array was employed to profile rhesus macaques vaccinated with a gp120‐CD4 fusion protein in combination with different genetically encoded adjuvants, and subsequently subjected to multiple heterologous simian immunodeficiency virus (SIV) challenges. Systems analyses modeling protection and adjuvant differences using Fab‐Fc Array measurements revealed a set of correlates yielding strong and robust predictive performance, while models based on measurements of response magnitude alone exhibited significantly inferior performance. At the same time, rendering Fab‐Fc measurements mathematically independent of titer had relatively little impact on predictive performance. Similar analyses for a distinct SIV vaccine study also showed that Fab‐Fc measurements performed significantly better than titer. These results suggest that predictive modeling with measurements of antibody properties can provide detailed correlates with robust predictive power, suggest directions for vaccine improvement, and potentially enable discovery of mechanistic associations.https://doi.org/10.15252/msb.20188747antibody effector functionbiomarker identificationHIVprotection modelingsystems serology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Srivamshi Pittala Kenneth Bagley Jennifer A Schwartz Eric P Brown Joshua A Weiner Ilia J Prado Wenlei Zhang Rong Xu Ayuko Ota‐Setlik Ranajit Pal Xiaoying Shen Charles Beck Guido Ferrari George K Lewis Celia C LaBranche David C Montefiori Georgia D Tomaras Galit Alter Mario Roederer Timothy R Fouts Margaret E Ackerman Chris Bailey‐Kellogg |
spellingShingle |
Srivamshi Pittala Kenneth Bagley Jennifer A Schwartz Eric P Brown Joshua A Weiner Ilia J Prado Wenlei Zhang Rong Xu Ayuko Ota‐Setlik Ranajit Pal Xiaoying Shen Charles Beck Guido Ferrari George K Lewis Celia C LaBranche David C Montefiori Georgia D Tomaras Galit Alter Mario Roederer Timothy R Fouts Margaret E Ackerman Chris Bailey‐Kellogg Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection Molecular Systems Biology antibody effector function biomarker identification HIV protection modeling systems serology |
author_facet |
Srivamshi Pittala Kenneth Bagley Jennifer A Schwartz Eric P Brown Joshua A Weiner Ilia J Prado Wenlei Zhang Rong Xu Ayuko Ota‐Setlik Ranajit Pal Xiaoying Shen Charles Beck Guido Ferrari George K Lewis Celia C LaBranche David C Montefiori Georgia D Tomaras Galit Alter Mario Roederer Timothy R Fouts Margaret E Ackerman Chris Bailey‐Kellogg |
author_sort |
Srivamshi Pittala |
title |
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection |
title_short |
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection |
title_full |
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection |
title_fullStr |
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection |
title_full_unstemmed |
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection |
title_sort |
antibody fab‐fc properties outperform titer in predictive models of siv vaccine‐induced protection |
publisher |
Wiley |
series |
Molecular Systems Biology |
issn |
1744-4292 |
publishDate |
2019-05-01 |
description |
Abstract Characterizing the antigen‐binding and innate immune‐recruiting properties of the humoral response offers the chance to obtain deeper insights into mechanisms of protection than revealed by measuring only overall antibody titer. Here, a high‐throughput, multiplexed Fab‐Fc Array was employed to profile rhesus macaques vaccinated with a gp120‐CD4 fusion protein in combination with different genetically encoded adjuvants, and subsequently subjected to multiple heterologous simian immunodeficiency virus (SIV) challenges. Systems analyses modeling protection and adjuvant differences using Fab‐Fc Array measurements revealed a set of correlates yielding strong and robust predictive performance, while models based on measurements of response magnitude alone exhibited significantly inferior performance. At the same time, rendering Fab‐Fc measurements mathematically independent of titer had relatively little impact on predictive performance. Similar analyses for a distinct SIV vaccine study also showed that Fab‐Fc measurements performed significantly better than titer. These results suggest that predictive modeling with measurements of antibody properties can provide detailed correlates with robust predictive power, suggest directions for vaccine improvement, and potentially enable discovery of mechanistic associations. |
topic |
antibody effector function biomarker identification HIV protection modeling systems serology |
url |
https://doi.org/10.15252/msb.20188747 |
work_keys_str_mv |
AT srivamshipittala antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT kennethbagley antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT jenniferaschwartz antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT ericpbrown antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT joshuaaweiner antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT iliajprado antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT wenleizhang antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT rongxu antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT ayukootasetlik antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT ranajitpal antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT xiaoyingshen antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT charlesbeck antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT guidoferrari antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT georgeklewis antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT celiaclabranche antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT davidcmontefiori antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT georgiadtomaras antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT galitalter antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT marioroederer antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT timothyrfouts antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT margareteackerman antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection AT chrisbaileykellogg antibodyfabfcpropertiesoutperformtiterinpredictivemodelsofsivvaccineinducedprotection |
_version_ |
1721240451976003584 |